Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Clearside Biomedical, Inc. (CLSD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Bought 10,000 shares
@ $0.86, valued at
$8.6k
|
|
| 01/20/2023 |
4
| Ciulla Thomas (Chief Medical Officer) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 13,700 shares
@ $1.47, valued at
$20.1k
|
|
| 01/20/2023 |
4
| LASEZKAY GEORGE M (CEO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 20,030 shares
@ $1.46, valued at
$29.2k
|
|
| 01/20/2023 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 14,030 shares
@ $1.5, valued at
$21k
|
|
| 01/11/2023 |
4
| Ciulla Thomas (Chief Medical Officer) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 2,170 shares
@ $1.62, valued at
$3.5k
|
|
| 01/06/2023 |
4
| LASEZKAY GEORGE M (CEO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 487,500 options to buy
@ $1.48, valued at
$721.5k
|
|
| 01/06/2023 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 187,500 options to buy
@ $1.48, valued at
$277.5k
|
|
| 01/06/2023 |
4
| Ciulla Thomas (Chief Medical Officer) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 5,000 shares
@ $1.25, valued at
$6.3k
Granted 5,000 shares
@ $0.95, valued at
$4.8k
Granted 187,500 options to buy
@ $1.48, valued at
$277.5k
|
|
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Bought 30,000 shares
@ $1.33, valued at
$39.9k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Croarkin Richard (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.62, valued at
$48.6k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Humphries William D. (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.62, valued at
$48.6k
|
|
| 06/24/2022 |
4
| Thorp Clay (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.62, valued at
$48.6k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 43,750 shares
@ $0
Sold 8,833 shares
@ $2.09, valued at
$18.5k
Granted 131,250 options to buy
@ $2.19, valued at
$287.4k
|
|
| 01/20/2022 |
4
| Ciulla Thomas (Chief Medical Officer) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 43,750 shares
@ $0
Sold 9,050 shares
@ $2.13, valued at
$19.3k
Granted 131,250 options to buy
@ $2.19, valued at
$287.4k
|
|
| 01/20/2022 |
4
| LASEZKAY GEORGE M (CEO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 97,500 shares
@ $0
Sold 10,800 shares
@ $2.12, valued at
$22.9k
Granted 292,500 options to buy
@ $2.19, valued at
$640.6k
|
|
| 01/13/2022 |
4
| LASEZKAY GEORGE M (CEO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 5,100 shares
@ $2.46, valued at
$12.5k
|
|
| 01/11/2022 |
4
| Humphries William D. (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Exercised 22,727 options to buy
@ $0.15, valued at
$3.4k
|
|
| 11/02/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Exercised 25,000 options to buy
@ $2, valued at
$50k
Exercised 15,000 options to buy
@ $2.09, valued at
$31.4k
|
|
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
4
| LASEZKAY GEORGE M (CEO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 3,525 shares
@ $6.46, valued at
$22.8k
|
|
| 09/23/2021 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 2,800 shares
@ $6.41, valued at
$17.9k
|
|
| 09/01/2021 |
4
| WHITMORE BRADFORD T (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 99,400 shares
@ $7.0634, valued at
$702.1k
Sold 107,682 shares
@ $6.9564, valued at
$749.1k
Sold 213,203 shares
@ $6.8913, valued at
$1.5M
|
|
| 08/17/2021 |
4
| Hutson Nancy J (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Bought 3,000 shares
@ $5.68, valued at
$17k
|
|
| 06/23/2021 |
4
| LASEZKAY GEORGE M (CEO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 3,707 shares
@ $4.38, valued at
$16.2k
|
|
| 06/23/2021 |
4
| Deignan Charles A. (CFO) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 2,938 shares
@ $4.37, valued at
$12.8k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|